These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19334376)

  • 1. [In vitro effect of reactive nitrogen and oxygen intermediates alone and in combination with some antibiotics against Brucella melitensis clinical isolates].
    Tanyel E; Coban AY; Taşdelen Fişgin N; Tülek N; Durupinar B
    Mikrobiyol Bul; 2009 Jan; 43(1):19-26. PubMed ID: 19334376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of tigecycline and ertapenem against clinical isolates of Brucella melitensis detected by E-test on different media.
    Tanyel E; Coban AY; Fisgin NT; Tulek N
    Indian J Med Microbiol; 2010; 28(4):370-1. PubMed ID: 20966572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro susceptibility of Salmonella enterica serovar Typhimurium to reactive oxygen and nitrogen products].
    Coban AY; Ekinci B; Durupinar B
    Mikrobiyol Bul; 2003 Jan; 37(1):27-33. PubMed ID: 12838675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
    Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
    Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
    Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
    Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey.
    Sayan M; Kılıc S; Uyanık MH
    J Infect Chemother; 2012 Feb; 18(1):41-6. PubMed ID: 21826587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
    Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
    Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
    Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
    BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acidified nitrite enhances hydrogen peroxide disinfection of Acanthamoeba, bacteria and fungi.
    Heaselgrave W; Andrew PW; Kilvington S
    J Antimicrob Chemother; 2010 Jun; 65(6):1207-14. PubMed ID: 20335189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
    Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
    BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.
    Marianelli C; Graziani C; Santangelo C; Xibilia MT; Imbriani A; Amato R; Neri D; Cuccia M; Rinnone S; Di Marco V; Ciuchini F
    J Clin Microbiol; 2007 Sep; 45(9):2923-8. PubMed ID: 17634297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
    Kilic S; Dizbay M; Cabadak H
    J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotypes and antimicrobial susceptibilities of Brucella isolates.
    Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
    Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rifampicin and tetracycline alone and in combination against Brucella suis.
    De Rycke J
    Ann Microbiol (Paris); 1980; 131B(3):277-87. PubMed ID: 7469256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of
    Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
    Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
    Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
    J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimicrobial susceptibility of Brucella species.
    Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
    Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline: its potential for treatment of brucellosis.
    Dizbay M; Kilic S; Hizel K; Arman D
    Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
    Sengöz G; Yaşar KK; Kutlu SB; Durdu YB; Ozdemir R; Nazlican O
    Mikrobiyol Bul; 2006 Jul; 40(3):265-8. PubMed ID: 17001857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant prevention concentrations of tetracycline, rifampicin and ciprofloxacin for Brucellae melitensis.
    Coban AY; Tanyel E; Tasdelen Fisgin N; Darka O; Tulek N; Durupinar B
    J Chemother; 2007 Oct; 19(5):596-8. PubMed ID: 18073161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.